Open original FDA record ↗Recall record
- FDA identifier
- Z-0919-2021
- Company in FDA record
- Hardy Diagnostics
- FDA record creation date
- Jan 25, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Complaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited.
Source facts
- Action
- On 12/21/2020, the firm sent an "URGENT: Medical Device Recall Notification" letter to customers via first class mail, email and/or facsimile informing them that seven customer complaints received of breakthrough of negative controls. Customers are instructed to: 1. Discard any remaining stock. The product should be destroyed according to local regulation as non-hazardous waste if un-inoculated, or as medical waste if inoculated. 2. Retain the Recall Notification and to notify any and all employees who may use the product. If the product was further distributed, to notify the consignees the product was distributed to. 3. Fill out the Product Recall Customer Inventory Form and to return the form within five (5) business days via e-mail to JohnsonL@HardyDiagnostics.com or by fax to (805)266-2222, option 2 or (805)361-5050 or via e-mail at TechnicalServices@HaryDiagnostics.com. For any questions or further information contact Technical Services Department at 800-266-2222 ext. 5598
- Initiated
- 2020-12-21
- Root cause
- Under Investigation by firm
- Terminated
- 2022-09-28
- Distribution
- U.S.: CA, UT, MI, Puerto Rico, IN, CT, AZ, GA, MA, TN, WA O.U.S. None
- Recall number
- Z-0919-2021
- Recall status
- Terminated
- CDRH record ID
- 185320
- FDA record created
- 2021-01-25
- Recall event number
- 87091